Femke Mathot

Chapter 10 180 REFERENCES 1. Rbia N, Shin AY. The Role of Nerve Graft Substitutes in Motor and Mixed Motor/Sensory Peripheral Nerve Injuries. J Hand Surg Am 2017: 42: 367-77. 2. FF IJ, Nicolai JP, Meek MF. Sural nerve donor-site morbidity: thirty-four years of follow-up. Ann Plast Surg 2006: 57: 391-5. 3. Hallgren A, Bjorkman A, Chemnitz A, Dahlin LB. Subjective outcome related to donor site morbidity after sural nerve graft harvesting: a survey in 41 patients. BMC Surg 2013: 13: 39. 4. Rbia N, Bulstra LF, Bishop AT, van Wijnen AJ, Shin AY. A simple dynamic strategy to deliver stem cells to decellularized nerve allografts. Plast Reconstr Surg 2018. 5. Orbay H, Uysal AC, Hyakusoku H, Mizuno H. Differentiated and undifferentiated adipose- derived stem cells improve function in rats with peripheral nerve gaps. J Plast Reconstr Aesthet Surg 2011. 6. Tomita K, Madura T, Sakai Y, et al. Glial differentiation of human adipose-derived stem cells: implications for cell-based transplantation therapy. Neuroscience 2013: 236: 55-65. 7. Wang D, Liu XL, Zhu JK, et al. Bridging small-gap peripheral nerve defects using acellular nerve allograft implanted with autologous bone marrow stromal cells in primates. Brain Res 2008: 1188: 44-53. 8. Sunderland S, Lavarack JO, Ray LJ. The caliber of nerve fibers in human cutaneous nerves. J COMP NEUROL 1949: 91: 87-101. 9. Ryu YJ, Cho TJ, Lee DS, Choi JY, Cho J. Phenotypic characterization and in vivo localization of human adipose-derived mesenchymal stem cells. Mol Cells 2013: 35: 557-64. 10. Ge J, Guo L, Wang S, et al. The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev 2014: 10: 295-303. 11. Garvican ER, Cree S, Bull L, Smith RK, Dudhia J. Viability of equine mesenchymal stem cells during transport and implantation. Stem Cell Res Ther 2014: 5: 94. 12. Agashi K, Chau DY, Shakesheff KM. The effect of delivery via narrow-bore needles on mesenchymal cells. Regen Med 2009: 4: 49-64. 13. Mamidi MK, Singh G, Husin JM, et al. Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. J Transl Med 2012: 10: 229. 14. Jesuraj NJ, Santosa KB, Newton P, et al. A systematic evaluation of Schwann cell injection into acellular cold-preserved nerve grafts. J Neurosci Methods 2011: 197: 209-15. 15. Thompson MJ, Patel G, Isaacs J, et al. Introduction of neurosupportive cells into processed acellular nerve allografts results in greater number and more even distribution when injected compared to soaking techniques. Neurol Res 2017: 39: 189-97. 16. Caplan AI, Hariri R. Body Management: Mesenchymal Stem Cells Control the Internal Regenerator. Stem Cells Transl Med 2015: 4: 695-701. 17. Caplan AI. Adult Mesenchymal Stem Cells: When, Where, and How. Stem Cells Int 2015: 2015: 628767. 18. Kingham PJ, Kolar MK, Novikova LN, Novikov LN, Wiberg M. Stimulating the neurotrophic and angiogenic properties of human adipose-derived stem cells enhances nerve repair. Stem Cells Dev 2014: 23: 741-54. 19. Lattanzi W, Geloso MC, Saulnier N, et al. Neurotrophic features of human adipose tissue- derived stromal cells: in vitro and in vivo studies. J Biomed Biotechnol 2011: 2011: 468705. 20. Kingham PJ, Kalbermatten DF, Mahay D, et al. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro. Exp Neurol 2007: 207: 267-74. 21. Zhao Z, Wang Y, Peng J, et al. Repair of nerve defect with acellular nerve graft supplemented by bone marrow stromal cells in mice. Microsurgery 2011: 31: 388-94. 22. Rbia N, Bulstra LF, Thaler R, et al. In Vivo Survival of Mesenchymal Stromal Cell-Enhanced Decellularized Nerve Grafts for Segmental Peripheral Nerve Reconstruction. J Hand Surg Am